11/19
04:19 pm
rcus
Arcus Biosciences to Participate in Two Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Arcus Biosciences to Participate in Two Upcoming Investor Conferences [Yahoo! Finance]
11/19
04:05 pm
rcus
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
Low
Report
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
11/12
04:35 pm
rcus
Arcus Biosciences Announces New Employment Inducement Grants
Low
Report
Arcus Biosciences Announces New Employment Inducement Grants
11/9
10:22 am
rcus
Analysts Have Made A Financial Statement On Arcus Biosciences, Inc.'s (NYSE:RCUS) Third-Quarter Report [Yahoo! Finance]
Low
Report
Analysts Have Made A Financial Statement On Arcus Biosciences, Inc.'s (NYSE:RCUS) Third-Quarter Report [Yahoo! Finance]
11/7
02:31 am
rcus
Arcus Biosciences Inc (RCUS) Q3 2024 Earnings Call Highlights: Strong Cash Position and ... [Yahoo! Finance]
Neutral
Report
Arcus Biosciences Inc (RCUS) Q3 2024 Earnings Call Highlights: Strong Cash Position and ... [Yahoo! Finance]
11/6
04:30 pm
rcus
Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update [Yahoo! Finance]
Low
Report
Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update [Yahoo! Finance]
11/6
04:22 pm
rcus
Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update
Medium
Report
Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update
11/6
08:07 am
rcus
Arcus Biosciences, Inc. (NYSE: RCUS) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Low
Report
Arcus Biosciences, Inc. (NYSE: RCUS) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
11/5
09:00 am
rcus
Arcus Biosciences Announces that Domvanalimab Plus Zimberelimab Improved Overall Survival in ARC-10, a Randomized Study in Patients with PD-L1-High Non-Small Cell Lung Cancer
Low
Report
Arcus Biosciences Announces that Domvanalimab Plus Zimberelimab Improved Overall Survival in ARC-10, a Randomized Study in Patients with PD-L1-High Non-Small Cell Lung Cancer
11/5
07:56 am
rcus
What To Expect From Arcus Biosciences Inc (RCUS) Q3 2024 Earnings [Yahoo! Finance]
Low
Report
What To Expect From Arcus Biosciences Inc (RCUS) Q3 2024 Earnings [Yahoo! Finance]
10/30
09:00 am
rcus
Arcus Biosciences to Present New Data for Anti-TIGIT Domvanalimab Plus Zimberelimab at the Society for Immunotherapy of Cancer Annual Meeting
Low
Report
Arcus Biosciences to Present New Data for Anti-TIGIT Domvanalimab Plus Zimberelimab at the Society for Immunotherapy of Cancer Annual Meeting
10/25
01:44 pm
rcus
Arcus Biosciences, Inc. (NYSE: RCUS) had its price target raised by analysts at Barclays PLC from $25.00 to $29.00. They now have an "overweight" rating on the stock.
Low
Report
Arcus Biosciences, Inc. (NYSE: RCUS) had its price target raised by analysts at Barclays PLC from $25.00 to $29.00. They now have an "overweight" rating on the stock.
10/24
04:35 pm
rcus
Arcus Biosciences Announces New Employment Inducement Grants
Medium
Report
Arcus Biosciences Announces New Employment Inducement Grants
10/24
07:30 am
rcus
First Clinical Data for Arcus Biosciences’ HIF-2a Inhibitor, Casdatifan, Showed Promising Clinical Activity and Tumor Shrinkage in Patients with Metastatic Kidney Cancer
Low
Report
First Clinical Data for Arcus Biosciences’ HIF-2a Inhibitor, Casdatifan, Showed Promising Clinical Activity and Tumor Shrinkage in Patients with Metastatic Kidney Cancer
10/22
04:05 pm
rcus
Arcus Biosciences to Host Conference Call to Discuss Third-Quarter 2024 Financial Results and Pipeline Update
Medium
Report
Arcus Biosciences to Host Conference Call to Discuss Third-Quarter 2024 Financial Results and Pipeline Update
10/21
08:07 am
rcus
Arcus Biosciences, Inc. (NYSE: RCUS) is now covered by analysts at HC Wainwright. They set a "neutral" rating and a $20.00 price target on the stock.
Medium
Report
Arcus Biosciences, Inc. (NYSE: RCUS) is now covered by analysts at HC Wainwright. They set a "neutral" rating and a $20.00 price target on the stock.
10/9
04:35 pm
rcus
Arcus Biosciences Announces New Employment Inducement Grants
Low
Report
Arcus Biosciences Announces New Employment Inducement Grants
10/9
08:39 am
rcus
Arcus Biosciences, Inc.'s (NYSE:RCUS) Intrinsic Value Is Potentially 30% Above Its Share Price [Yahoo! Finance]
Low
Report
Arcus Biosciences, Inc.'s (NYSE:RCUS) Intrinsic Value Is Potentially 30% Above Its Share Price [Yahoo! Finance]
10/9
08:00 am
rcus
Arcus Biosciences to Present First Clinical Data from ARC-20 Study at the 2024 EORTC-NCI-AACR Symposium
Low
Report
Arcus Biosciences to Present First Clinical Data from ARC-20 Study at the 2024 EORTC-NCI-AACR Symposium
10/8
08:39 am
rcus
Arcus Biosciences, Inc. (NYSE: RCUS) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $29.00 price target on the stock.
Low
Report
Arcus Biosciences, Inc. (NYSE: RCUS) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $29.00 price target on the stock.
10/3
11:07 am
rcus
Arcus Biosciences, Inc. (NYSE: RCUS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Low
Report
Arcus Biosciences, Inc. (NYSE: RCUS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
10/3
10:07 am
rcus
Arcus Biosciences, Inc. (NYSE: RCUS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $30.00 price target on the stock.
Low
Report
Arcus Biosciences, Inc. (NYSE: RCUS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $30.00 price target on the stock.
10/2
04:05 pm
rcus
Arcus Biosciences Announces Clinical Trial Collaboration Agreement to Evaluate Casdatifan in Combination with Volrustomig in Renal Cell Carcinoma
Low
Report
Arcus Biosciences Announces Clinical Trial Collaboration Agreement to Evaluate Casdatifan in Combination with Volrustomig in Renal Cell Carcinoma
9/24
04:35 pm
rcus
Arcus Biosciences Announces New Employment Inducement Grants
Low
Report
Arcus Biosciences Announces New Employment Inducement Grants
9/10
04:35 pm
rcus
Arcus Biosciences Announces New Employment Inducement Grants
Low
Report
Arcus Biosciences Announces New Employment Inducement Grants